27 results on '"Tu, Shi‐Ming"'
Search Results
2. Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment
3. Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report
4. Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer
5. Positive FDG-PET/CT Scans of a Residual Seminoma After Chemotherapy and Radiotherapy: Case Report and Review of the Literature
6. Stem Cell Origin of Testicular Seminoma
7. Cixutumumab-Associated Pancolitis in a Patient With Prostate Cancer
8. Prostate Cancer Stem Cells
9. Prolonged Remission of Fulminant Castrate-Resistant Prostate Cancer: A Case Report
10. Pilot Trial of Bone-Targeted Therapy Combining Zoledronate With Fluvastatin or Atorvastatin for Patients With Metastatic Renal Cell Carcinoma
11. Effect of Diethylstilbestrol on Levels of Prostate Specific Antigen and Clotting Factor in Patients with Recurrent Prostate Cancer: 1124447
12. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection
13. Multisystem Crisis in a Patient with Presumptive Renal Cell Carcinoma
14. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: Can we predict patients at risk of disease progression?
15. Surgical Management of Growing Teratoma Syndrome: The M. D. Anderson Cancer Center Experience
16. Prostate Cancer Progression in the Presence of Undetectable Or Low Serum Prostate-Specific Antigen Level
17. Recurrence Pattern and Proposed Surveillance Protocol Following Post-Chemotherapy Retroperitoneal Lymph Node Dissection
18. The central role of osteoblasts in the metastasis of prostate cancer
19. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: Can it be predicted using clinical parameters?
20. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer
21. Pilot Trial of Bone-Targeted Therapy With Zoledronate, Thalidomide, and Interferon-γ for Metastatic Renal Cell Carcinoma
22. Therapy Tolerance in Selected Patients With Androgen-Independent Prostate Cancer Following Strontium-89 Combined With Chemotherapy
23. Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer
24. Re: A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients with Hormone-Refractory Metastatic Prostate Carcinoma
25. Results of a Phase II Study With Doxorubicin, Etoposide, and Cisplatin in Patients With Fully Characterized Small-Cell Carcinoma of the Prostate
26. Cisplatin, Gemcitabine, and Ifosfamide As Weekly Therapy: A Feasibility and Phase II Study of Salvage Treatment for Advanced Transitional-Cell Carcinoma
27. Phase III Trial of Fluorouracil, Interferon Alfa-2b, and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Metastatic or Unresectable Urothelial Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.